Comparing care options for advanced kidney disease patients
Defining Optimal Transitions of Care in Advanced Kidney Disease: Conservative Management vs. Dialysis Approaches
This study is looking at the best ways to help people with advanced kidney disease, especially older adults and those with other health problems, by comparing the benefits of starting dialysis versus choosing gentler treatment options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10830431 on NIH RePORTER |
What this research studies
This research investigates the best ways to manage advanced kidney disease, focusing on whether patients should transition to dialysis or consider conservative management options. It aims to understand the effectiveness of these approaches on patient outcomes, particularly for elderly patients and those with multiple health issues. By analyzing data from previous studies, the research seeks to identify which patients might benefit most from avoiding dialysis and instead opting for less invasive treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research include elderly patients or those with multiple health conditions who are facing advanced kidney disease.
Not a fit: Patients who are not experiencing advanced kidney disease or those who are already on dialysis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and better quality of life for patients with advanced kidney disease.
How similar studies have performed: Previous research has indicated that conservative management can be a viable alternative to dialysis, but this specific approach is still being explored for its effectiveness.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Rhee, Connie Meeyoung — University of California Los Angeles
- Study coordinator: Rhee, Connie Meeyoung
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.